Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Zantac Syrup Recall Issued Over Excessive NDMA Levels November 26, 2019 Irvin Jackson Add Your CommentsA generic version of Zantac syrup is the latest ranitidine-based heartburn drug to be recalled, since it may expose users to excessive levels of the cancer-causing chemical N-Nitrosodimethylamine (NDMA).Over the past few months, a number ofย Zantac recalls have been issued by manufacturers of name-brand, over-the-counter and generic version of the popular medication, which each contain the active pharmaceutical ingredient ranitidine, which has been found to product high levels of NDMA when exposed to certain conditions or inside the body.The FDA announced a generic Zantac syrup recall on November 22, impacting oral solutions sold by Amneal Pharmaceuticals. The company is also recalling generic ranitidine tablets sold in 150mg and 300mg doses.Stay Up-to-Date AboutZantac LawsuitsAboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits, and safety warnings that may impact your family, including any new Zantac lawsuit updates or legal developments. "*" indicates required fieldsEmail* SIGN ME UPΔ Learn MoreStay Up-to-Date AboutZantac LawsuitsAboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits, and safety warnings that may impact your family, including any new Zantac lawsuit updates or legal developments."*" indicates required fieldsEmail* SIGN ME UPΔ Learn MoreWhile no adverse events have been linked to these recalled Zantac products, exposure to NDMA found in the drug has been linked to reports of bladder cancer, stomach cancer, esophageal cancer, colorectal cancer and other cancers along the digestive tract as the chemical travels through the body.The FDA first warned about the Zantac NDMA problemsย on September 13, indicating several different versions of the heartburn drug were found to contain the cancer-causing impurity. As a result, major retailers haveย removed Zantac from store shelves, and nearly every version of the medication has now been recalled.The latest recall affects Ranitidine Syrup (Ranitidine Oral Solution, USP) 15 mg/mL sold in 473 mL pack size, and Ranitidine Tablets, USP 150 mg and 300 mg, sold in 30, 60, 100, 180, 250, 500, and 1,000-count bottles. A full list of recalled lots and NDC numbers is available in the recall notice.All of the recalled generic Zantac products were manufactured by Amneal Pharmaceuticals, LLC, based in Bridgewater, New Jersey, and were available by prescription only. They were distributed to wholesalers, distributors, retailers and repackagers nationwide.Amneal indicates it is notifying customers by UPS Standard Overnight mail through a recall notification letter and arranging for the return of all recalled products. The company recommends anyone with an inventory of the affected products quarantine them immediately.Customers with impacted products can call Stericycle at 866-918-8768 to arrange for the products return. Consumers with questions or who had adverse event reactions can call Amneal Drug Safety at 1-877-835-5472 or send an e-mail to DrugSafety@amneal.com.Zantac Cancer ProblemsZantac (ranitidine) has been on the market for decades, and has been regularly used by millions of Americans for treatment of heart burn and acid reflux. However, increasing evidence now suggests the active ingredient ranitidine is inherently unstable, and may convert to NDMA at levels that are not safe.The online pharmacy Valisure first brought the problems the attention of regulators, filing a citizenโs petition that called for all versions of Zantac to be removed the drug from the market, and for consumers to be provided instructions about the safe disposal of the medication to avoid widespread water contamination. The group also sent a copy of the petition to the World Health Organization, indicating that ranitidine in Zantac should be considered a human carcinogen.According to independent testing by Valisure, levels of NDMA in one Zantac 150mg tablet may exceed 3,000,000 nanograms (ng), which is 26,000 times higher than the FDAโs permissible daily intake for the chemical. Excessive NDMA levels were detected across all brands of Zantac and all lots, and Valisure indicated research dating back 20 years has included warning signs about potential problems with the drug.While drug makers and federal regulators indicate that they are continuing to investigate the Zantac problems, many consumers are now questioning whether they may have avoided a cancer diagnosis if other available alternative treatments for heartburn had been used.A growing number ofย Zantac lawsuitsย are now being pursued by individuals diagnosed with bladder cancer, stomach cancer, small intestine cancer, colorectal cancer, esophageal cancer and other problems impacting the digestive tract as NDMC from ranitidine moved through the body. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Cancer, Drug Recall, Heartburn, Heartburn Drug, NDMA, ZantacMore Zantac Lawsuit Stories Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall June 18, 2025 Jury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim February 5, 2025 Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California November 22, 2024 0 CommentsURLThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (Posted: 2 days ago)A man’s lawsuit blames pesticides for his development of Parkinson’s disease after living near nurseries in California for nearly 20 years.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (09/23/2026) Olympus Wrongful Death Lawsuit Judge Calls for Quick Resolution (Posted: 3 days ago)A wrongful death lawsuit filed against Olympus Medical over an alleged medical scope infection could be ready for trial in about a year.MORE ABOUT: SCOPE INFECTION LAWSUITOlympus Scope Problems Lead to FDA Import Warning (10/27/2026)Fujifilm and Olympus Scope Infection Risks Highlight Growing Need for Advanced Disinfection Systems: Report (10/19/2026)Olympus Medical Device Warning Letter Follows FDA Inspections of Six Manufacturing Facilities (10/16/2026) Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials (Posted: 4 days ago)Attorneys in Bard PowerPort lawsuits have asked a federal judge to suspend pretrial proceedings while the parties engage in settlement negotiations seeking to resolve the litigation.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (11/03/2026)Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026)
Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (Posted: 2 days ago)A man’s lawsuit blames pesticides for his development of Parkinson’s disease after living near nurseries in California for nearly 20 years.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (09/23/2026)
Olympus Wrongful Death Lawsuit Judge Calls for Quick Resolution (Posted: 3 days ago)A wrongful death lawsuit filed against Olympus Medical over an alleged medical scope infection could be ready for trial in about a year.MORE ABOUT: SCOPE INFECTION LAWSUITOlympus Scope Problems Lead to FDA Import Warning (10/27/2026)Fujifilm and Olympus Scope Infection Risks Highlight Growing Need for Advanced Disinfection Systems: Report (10/19/2026)Olympus Medical Device Warning Letter Follows FDA Inspections of Six Manufacturing Facilities (10/16/2026)
Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials (Posted: 4 days ago)Attorneys in Bard PowerPort lawsuits have asked a federal judge to suspend pretrial proceedings while the parties engage in settlement negotiations seeking to resolve the litigation.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (11/03/2026)Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026)